Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study
Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study
Children with aggressive leukaemia experiencing remission with T cell therapy
ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy
Overall survival update from the BREAK-3 study
A short tour of the p-medicine ALGA-C Profiler
A short tour of the p-medicine ALGA-C Questionnaire
A short tour of the p-medicine Workbench Tool
A short tour of the p-medicine Custodix Anonymisation Tool
A short tour of the p-medicine Ontology Annotator Tool
Highlights of the EORTC-NCI-AACR Symposium
Predicting the relapse of acute myeloid leukaemia with genetic screening
Choosing personalised treatment options based on molecular evidence